Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-037682
Filing Date
2015-05-13
Accepted
2015-05-13 16:01:35
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7920_110q.htm 10-Q 983032
2 EX-10.22 a15-7920_1ex10d22.htm EX-10.22 20274
3 EX-31.1 a15-7920_1ex31d1.htm EX-31.1 8877
4 EX-31.2 a15-7920_1ex31d2.htm EX-31.2 8914
5 EX-32.1 a15-7920_1ex32d1.htm EX-32.1 9225
12 GRAPHIC g79201ksi001.jpg GRAPHIC 5565
  Complete submission text file 0001104659-15-037682.txt   5587412

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adms-20150331.xml EX-101.INS 799833
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20150331.xsd EX-101.SCH 36151
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20150331_cal.xml EX-101.CAL 36000
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20150331_def.xml EX-101.DEF 126831
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT adms-20150331_lab.xml EX-101.LAB 369126
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20150331_pre.xml EX-101.PRE 245380
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 15858327
SIC: 2834 Pharmaceutical Preparations